Dr. Susan Lauren Rusnack, MD

Dr. Rusnack practices at Tower Outpatient Surgery Center in Los Angeles, California.

Dr. Rusnack's NPI, 1790957504, was assigned on April 1, 2008. Dr. Rusnack graduated from Sidney Kimmel Medical College in 2002. Dr. Rusnack holds California license C128392.

Dr. Rusnack's primary practice is Tower Outpatient Surgery Center, at 8635 W 3rd St, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 659-9408.

Dr. Rusnack's primary practice is Tower Outpatient Surgery Center in Los Angeles, California. Dr. Rusnack is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Tower Urology. Dmand AI also links Dr. Rusnack to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rusnack practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Rusnack's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Rusnack is board certified in urology by the American Board of Urology. Dmand AI has Dr. Rusnack's licenses on file in 3 states: California, New Jersey and New York.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, pelvic prolapse and transurethral procedures among the conditions Dr. Rusnack treats.

CMS data shows 24,348 Medicare services from Dr. Rusnack across 50 procedure codes in 2024, for 874 Medicare patients. Medicare paid $392,086 for them.

CMS counts 874 Medicare patients who saw Dr. Rusnack in 2026. The largest group is 75 to 84, with 402 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rusnack's median patient age at 77, with 83% women.

In 2026, Dr. Rusnack wrote 2,382 Medicare Part D claims for 553 patients. 63% of them were for generic drugs. CMS names the drug for 2,262 of them, across 28 drugs with 11 or more claims each, at $548,985 in total drug cost. In 2023, CMS named 2,233 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rusnack for performance year 2026, reported individually. Dr. Rusnack accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rusnack as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Rusnack. Dr. Rusnack's most frequent co-author is Michael C. Carr, MD.

CMS Open Payments shows 298 general payments to Dr. Rusnack from 52 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $1,494.

Dmand AI lists 1 award for Dr. Rusnack, most recently CMS Stage 1 EHR in 2012.

Dr. Rusnack graduated from Sidney Kimmel Medical College in 2002. Dr. Rusnack is a member of AMA, AUA, CMA and SLS.

Dr. Rusnack is in network with 4 carriers, including Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Michigan and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.